Description
The report includes both macro and micro-level insights, enabling readers to grasp key dynamics across segments, regions, and product categories.
from Apr 17, 2026 hours 15:58 (UTC +05:30)
to Apr 17, 2028 hours 15:58 (UTC +05:30)
India
from Apr 17, 2026 hours 15:58 (UTC +05:30)
to Apr 17, 2028 hours 15:58 (UTC +05:30)
The report includes both macro and micro-level insights, enabling readers to grasp key dynamics across segments, regions, and product categories.
Roots Analysis recently published a report on the global ADME Toxicology Testing Market growth. With a focus on historical trends, current developments, and future projections, it offers a data-rich foundation for decision-makers, industry participants, and investors. The report includes both macro and micro-level insights, enabling readers to grasp key dynamics across segments, regions, and product categories.
Market Size and Forecast
Current Market Size:USD 6.0 billion
Future Market Size: USD 6.0 billion
CAGR: ~3.9%
Market Overview
This growth is calculated based on observed trends, actual industry performance, and current developments in product usage and adoption. The study takes into account the challenges faced by key players and the general market structure, while avoiding speculative interpretations. It focuses on providing a clear picture of market performance across different regions and segments.
This report supports strategic planning by delivering verified data, cross-segment comparisons, and actionable insights—available in both PDF and spreadsheet formats for ease of integration.
Market Scope and Segmentation
- Historical Trend: 2019-2025
- Base Year: 2025
- Forecast Period: 2026-2030
- Market Size 2030: USD 6.0 billion
- Market CAGR: ~3.9%
- Type of Services
• Absorption
• Distribution
• Metabolism
• Excretion
- Type of Assays
• Batch / Fed-Batch
• Continuous
- Type of Molecules
• Biologics
• Small Molecules
- End Users
• Pharmaceutical and Biotechnology Companies
• Academic / Research Institutes
- Therapeutic Areas
• Blood Disorder
• Cardiovascular Disorder
• Gastrointestinal and Vascular Disorder
• Hormonal Disorder
• Infectious Diseases
• Immunological Disorders
• Mental Disorders
• Metabolic Disorders
• Neurological Disorders
• Oncology Disorders
• Respiratory Disorders
- Key Geographical Regions
• North America
• Europe
• Asia-Pacific
• Rest of the World
- Key Companies Profiled
• Charles River Laboratories
• Eurofins Scientific
• Evotec
• Galapagos
• GVK Biosciences
• Pharmaron
• Pharmaceutical Product Development (PPD)
• RTI International
• Sai Life Sciences
• Shanghai Medicilon
• Syngene International
• Tecan Group
• WuXi AppTec
- PowerPoint Presentation(Complimentary): Available
- Customization Scope: 15% Free Customization
- Excel Data Packs(Complimentary)
• Market Landscape
• Product Competitiveness Analysis
• Patent Analysis
• Market Forecast and Future Opportunity Analysis
Read More: https://www.rootsanalysis.com/reports/adme-toxicology-testing-market/239.html
By Region
North America, Europe, Asia-Pacific, Rest of the World
This segmentation structure provides a clear framework for understanding market dynamics, segment-specific trends, and growth opportunities.
Technological and Strategic Insights
The Roots Analysis report includes a detailed assessment of:
These insights are presented neutrally, supported by empirical evidence and primary research validation.
Key Market Players
Profiles of prominent companies include:
Charles River Laboratories, Eurofins Scientific, Evotec, Galapagos, GVK Biosciences, Pharmaron, Pharmaceutical Product Development (PPD), RTI International, Sai Life Sciences, Shanghai Medicilon, Syngene International, Tecan Group, WuXi AppTec
Each profile highlights:
Regional Insights
Each region is analyzed based on:
Comparative insights across regions enable targeted market entry and expansion strategies.
Report Structure
If the email address you entered is the one you registered with, we will shortly send you an email with all the information to reset your password.